Medtech 360

December 2013

US Markets for Facial Injectables 2014

Introduction:

The US market for facial injectables will grow at a moderate pace through 2022, driven primarily by high patient demand for aesthetic procedures.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables in US across a 10-year period.

We have up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   The US market for facial injectables will grow moderately through 2022

What factors are driving growth and which market segments have the most potential for growth over the forecast period?

Who are the major competitors in the market and how do they compete with one another for market share?

Which segments have the most potential for innovation and emerging technologies?

  *   As of 2013, BTX accounted for over half of facial injectable revenues.

What factors explain the popularity of this segment compared to dermal fillers?

What types of patients are seeking BTX procedures?

  *   In January 2013, the injunction placed by the FDA on Merz Pharma's XEOMIN BTX product and Belotero Balance HA filler was lifted.

What impact did the injunction have on the market?

Now that the injunction has been lifted, how will these new products affect ASPs in their respective segments?

  *   New competitors and products are expected to enter the facial injectable market, resulting in competitive pricing pressures.

How will these new competitors and products affect ASPs and the overall market?

Scope:

Geographies Covered: US

Procedures Covered: Millennium Research Group's analysis uses the following breakdown of procedures:

Product Type

BTX

Brand*

BOTOX Cosmetic

Dysport

Other**

Dermal Fillers

Material

HA

Other***

Anatomy

Glabellar Complex

Forehead

Periorbital Area

Nasolabial Folds

Lips

Mouth Area

Cheeks

Chin

Other****

Notes: (1) *Discussed qualitatively only (2) **Other includes XEOMIN and MYOBLOC (3) ***Other includes semipermanent and nonpermanent dermal fillers (4) ****Other includes earlobes as well as facial areas that are prone to scarring

Products Covered: Millennium Research Group's analysis uses the following breakdown of products in the market:

Product Type

BTX

Dermal Fillers

Material

HA

Other*

Notes: *Other includes semipermanent and nonpermanent dermal fillers

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

Dongho (David) Lee

Contributors
Samuli Heilala, M.Sc.
Veronica Ross
Jackie Tang, M.Sc.



Search Reports

Mentioned in this report:

  • Aesthetic Factors
  • Allergan
  • Anika Therapeutics
  • BeautyWorksWest
  • Biocompatibles
  • Clarion Medical
  • ColBar LifeScience
  • Contura
  • Croma-Pharma
  • Daewoong Pharmaceutical
  • Dermik Laboratories
  • Dove Spa
  • Fibrocell Science
  • Galderma
  • Galway Natural Health
  • Ipsen
  • Johnson & Johnson
  • Kaylight
  • Laboratoires TEOXANE
  • LIBP
  • Medicis
  • Medytox
  • Mentor
  • Merz Pharma
  • Prollenium Medical Technologies
  • Q-Med
  • Revance Therapeutics
  • Sanofi
  • Solstice Neurosciences
  • Suneva Medical
  • US WorldMeds
  • Valeant Pharmaceuticals International
Decision Resources Group brands include: